Economic Burden and Risk of Cardiovascular Disease and Diabetes in Patients with Different Cardiometabolic Risk Profiles

This publication has 28 references indexed in Scilit:

• Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation Among Adults in the U.S.
  Diabetes Care, 2005
• The Metabolic Syndrome: Time for a Critical Appraisal
  Diabetes Care, 2005
• The metabolic syndrome—a new worldwide definition
  The Lancet, 2005
• Interaction of Body Mass Index and Framingham Risk Score in Predicting Incident Coronary Disease in Families
  Circulation, 2005
• A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
  Diabetologia, 2004
• Description and validation of a Markov model of survival for individuals free of cardiovascular disease that uses Framingham risk factors
  BMC Medical Informatics and Decision Making, 2004
• Blood Pressure Lowering and Life Expectancy Based on a Markov Model of Cardiovascular Events
  Hypertension, 2003
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Expected gains in life expectancy from various coronary heart disease risk factor modifications.
  Circulation, 1991
• Cardiovascular disease risk profiles
  American Heart Journal, 1991